Shares of Florida-based cannabis multi-state operator (MSO) Trulieve Cannabis (CSE:TRUL,OTC Pink:TCNNF) saw a double-digit jump thanks to the start of smokables in the state.

The company confirmed the start of sales for smokable items on Thursday (March 21), with the first sale taking place at its Tallahassee dispensary.


On Monday (March 18), Florida Governor Ron DeSantis officially removed the ban on smokable cannabis products, according to a report from the Tallahassee Democrat.

The state faced a lawsuit and the eventual vote supported lifting the ban and allowing the sale of these products.

“Offering these whole flower products to our patients in their purest, most effective form is something we — and patients — have been looking forward to since we opened the doors of the state’s first dispensary,” Kim Rivers, CEO of Trulieve, said in a press release.

Trulieve had an 11.35-percent bump to its share price and finished the trading day at C$18.35 per share.

The company holds a market capitalization of C$136.2 million.

Trulieve, which has 26 dispensaries in the state, informed shareholders that Florida now has over 190,000 registered patients capable of buying medical-marijuana products.

During its fiscal Q4 2018 results conference call, Joseph Lusardi, CEO of fellow MSO Curaleaf (CSE:CURA,OTCQX:CURLF), said the company now expects the Florida market to double thanks to the change in the state.

The executive added that he also now expects to see some form of policy on edibles this year. Curaleaf currently operates 22 stores in Florida.

Despite its status as a medical-only market, Florida has quickly ascended as one of the top states in the minds of analysts.

Both Neal Gilmer, an analyst with Haywood Securities, and Matt Bottomley, director of equity research at Canaccord Genuity Group (TSX:CF), have expressed bullish sentiment for the state.

The market has attracted the attention of fellow MSO Cresco Labs (CSE:CL,OTCQX:CRLBF).

Alongside the lift on the smokable products on Monday, the firm announced it will pay US$120 million for the acquisition of VidaCann.

This venture holds in its portfolio seven active dispensaries. Additionally, three new stores have been completed and are only missing operational approval, with four extra stores set to be under construction by June.

According to research from the Arcview Market Research and BDS Analytics, the Florida cannabis market is estimated to be worth US$1.7 billion by 2022.

During the Canaccord Growth Investor Day event in Vancouver, Rivers told the audience she is not expecting to see a vote on adult-use marijuana until the 2024 elections.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Green Growth Brands is a client of the Investing News Network. This article is not paid-for content.

Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ retail stores, today announced that its executive team will participate in the following conference in March 2021:

Needham 2 nd Annual Virtual Cannabis Conference, March 3, 2021: Management will participate in one-on-one meetings.

Keep reading... Show less

In the cannabis space this week, retailer Fire & Flower Holdings (TSX:FAF,OTCQX:FFLWF) told investors it will be entering the US market through a novel strategic action.

Meanwhile, two longstanding cannabis partners ended their relationship.

Keep reading... Show less

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less